News

Boris Zemelman has been influential in the field of optogenetics, which is producing insights that could uncork a flood of new therapies.

Jonathan Sessler knows the odds of bringing effective new cancer treatments to market are stacked against him, yet he tirelessly pushes ahead.

A new study finds that the Freshman Research Initiative (FRI) experience translates to higher earnings for participants later on.

Mike Ryan, professor of integrative biology, has a new book that explores the intersection of evolution and aesthetics.

Leticia Nogueira talks about being the Director of Health Services for the American Cancer Society, what her research focuses on, and what she hopes to...

Three leaders in science and engineering discuss the obstacles for women and racial minorities to enter or stay in STEM.